YES1 as a Possible Liquid Biopsy Biomarker in Lung Cancer

• N. Otegui,
• E. Redin,
• E. Janthus-Lewintre,
• S. Calabuig,
• M. Echepare,
• K. Valencia,
• S. Leon,
• M. Serrano,
• C. Camps,
• L. Montuenga,
• A. Calvo

Affiliations

N. Otegui

Program in Solid Tumors, CIMA, Pamplona, Spain

E. Redin

Program in Solid Tumors, CIMA, Pamplona, Spain

E. Janthus-Lewintre

CIBERONC, Madrid, Spain; Mixed Unit TRIAL (Príncipe Felipe Research Centre & Fundación para la Investigación del Hospital General Universitario de Valencia), Valencia, Spain

S. Calabuig

CIBERONC, Madrid, Spain; Mixed Unit TRIAL (Príncipe Felipe Research Centre & Fundación para la Investigación del Hospital General Universitario de Valencia), Valencia, Spain

M. Echepare

Program in Solid Tumors, CIMA, Pamplona, Spain; IDISNA, Pamplona, Spain

K. Valencia

Program in Solid Tumors, CIMA, Pamplona, Spain; IDISNA, Pamplona, Spain

S. Leon

Program in Solid Tumors, CIMA, Pamplona, Spain

M. Serrano

Oncology Unit, Centre for Genomics and Oncological Research-GENYO, Pfizer, Granada, Spain

C. Camps

CIBERONC, Madrid, Spain; Mixed Unit TRIAL (Príncipe Felipe Research Centre & Fundación para la Investigación del Hospital General Universitario de Valencia), Valencia, Spain

L. Montuenga

Program in Solid Tumors, CIMA, Pamplona, Spain; IDISNA, Pamplona, Spain; CIBERONC, Madrid, Spain

A. Calvo

Program in Solid Tumors, CIMA, Pamplona, Spain; IDISNA, Pamplona, Spain; CIBERONC, Madrid, Spain